Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.39 |
| ▸ | CA2 | P00918 | 3/20 | 0.39 |
| ▸ | CA4 | P22748 | 2/20 | 0.39 |
| ▸ | CES2 | O00748 | 2/20 | 0.37 |
| ▸ | CES1 | P23141 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | RIPK1 | Q13546 | 4/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18803184 | 0.83 | ELANE (0.44) | CA1CA2CA4CES2CES1 | |
| SCHEMBL40376 | 0.82 | TSHR (0.35) | CA1CA2NR3C1 | |
| SCHEMBL10181456 | 0.82 | CES2 (0.42) | CES2CES1RIPK1 | |
| SCHEMBL17552762 | 0.81 | RIPK1 (0.46) | CA1CA2CA4MAPTKDM4E | |
| SCHEMBL19402718 | 0.81 | RIPK1 (0.36) | CA1CA2CA4CES2CES1 | |
| SCHEMBL10181736 | 0.79 | CES2 (0.41) | CA1CA2CA4CES2CES1 | |
| SCHEMBL10181554 | 0.79 | CES2 (0.38) | CES2CES1RIPK1 | |
| SCHEMBL17740107 | 0.78 | CA1 (0.41) | CA1CA2CA4CES2CES1 | |
| SCHEMBL24635135 | 0.78 | ELANE (0.36) | CA1CA2CA4CES2CES1 | |
| SCHEMBL18697369 | 0.78 | CA1 (0.44) | CA1CA2CA4CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 312 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1520177-B1 | METHOD AND REAGENT FOR SPECIFICALLY IDENTIFYING AND QUANTIFYING ONE OR MORE PROTEINS IN A SAMPLE | PROTEOME FACTORY AG (DE) | 2014-05-07 | — | — | EP | claimed |
| US-20140017797-A1 | PROTEIN AFFINITY TAG AND USES THEREOF | De Staadt der Nederlanden, vert doorde minister van VWS (NL) | 2014-01-16 | — | — | US | claimed |
| EP-2651961-A1 | PROTEIN AFFINITY TAG AND USES THEREOF | De Staat Der Nederlanden, Vert. Door De Minister Van VWS (NL) | 2013-10-23 | — | — | EP | claimed |
| WO-2012081978-A1 | PROTEIN AFFINITY TAG AND USES THEREOF | DE STAAT DER NEDERLANDEN, VERT. DOOR DE MINISTER VAN VWS (NL) | 2012-06-21 | — | — | WO | claimed |
| WO-2012034613-A3 | REFRIGERATOR | RED BULL GMBH (AT) | 2012-05-10 | — | — | WO | claimed |
| EP-1329513-B1 | Rapid quantitative analysis of proteins or protein function in complex mixtures | UNIV WASHINGTON (US) | 2011-12-07 | — | — | EP | claimed |
| US-20060246530-A1 | Method and reagent for the specifically identifying and quantifying one or more proteins in a sample | PROTEOME FACTORY AG (DE) | 2006-11-02 | — | — | US | claimed |
| EP-1520177-A2 | METHOD AND REAGENT FOR SPECIFICALLY IDENTIFYING AND QUANTIFYING ONE OR MORE PROTEINS IN A SAMPLE | Proteome Factory AG (DE) | 2005-04-06 | — | — | EP | claimed |
| US-6852544-B2 | Rapid quantitative analysis of proteins or protein function in complex mixtures | UNIVERSITY OF WASHINGTON (US) | 2005-02-08 | — | — | US | claimed |
| WO-2004001420-A2 | METHOD AND REAGENT FOR SPECIFICALLY IDENTIFYING AND QUANTIFYING ONE OR MORE PROTEINS IN A SAMPLE | PROTEOME FACTORY AG (DE) | 2003-12-31 | — | — | WO | claimed |
| US-6670194-B1 | Mass spectrometry; screening for changes in the expression of enzymatic activity of specific proteins induced by absence, deficiency or excess of a given protein | UNIVERSITY OF WASHINGTON | 2003-12-30 | — | — | US | claimed |
| EP-1105517-B1 | RAPID QUANTITATIVE ANALYSIS OF PROTEINS OR PROTEIN FUNCTION IN COMPLEX MIXTURES | UNIV WASHINGTON (US) | 2003-10-29 | — | — | EP | claimed |
| EP-1329513-A1 | Rapid quantitative analysis of proteins or protein function in complex mixtures | UNIVERSITY OF WASHINGTON (US) | 2003-07-23 | — | — | EP | claimed |
| US-20030087322-A9 | Rapid quantitative analysis of proteins or protein function in complex mixtures | UNIVERSITY OF WASHINGTON | 2003-05-08 | — | — | US | claimed |
| JP-2002523058-A | — | — | 2002-07-30 | — | — | JP | claimed |
| US-20020076739-A1 | Rapid quantitative analysis of proteins or protein function in complex mixtures | UNIVERSITY OF WASHINGTON | 2002-06-20 | — | — | US | claimed |
| EP-1105517-A4 | RAPID QUANTITATIVE ANALYSIS OF PROTEINS OR PROTEIN FUNCTION IN COMPLEX MIXTURES | UNIV WASHINGTON (US) | 2001-09-19 | — | — | EP | claimed |
| EP-1105517-A1 | RAPID QUANTITATIVE ANALYSIS OF PROTEINS OR PROTEIN FUNCTION IN COMPLEX MIXTURES | UNIVERSITY OF WASHINGTON (US) | 2001-06-13 | — | — | EP | claimed |
| WO-2000011208-A1 | RAPID QUANTITATIVE ANALYSIS OF PROTEINS OR PROTEIN FUNCTION IN COMPLEX MIXTURES | UNIVERSITY OF WASHINGTON (US) | 2000-03-02 | — | — | WO | claimed |
| EP-4638745-A1 | NOVEL FAS RNAI THERAPEUTICS AND USES THEREOF | Eli Lilly and Company (US) | 2025-10-29 | — | — | EP | disclosed |
| EP-3581195-B1 | ANTIBODIES TO OLANZAPINE HAPTENS AND USE THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2025-10-01 | — | — | EP | disclosed |
| EP-3492473-B1 | HAPTENS OF OLANZAPINE | JANSSEN PHARMACEUTICA NV (BE) | 2025-07-30 | — | — | EP | disclosed |
| EP-4444301-A1 | PRODRUGS FOR COMPOUNDS SPECIFIC TO GRANZYME B AND USES THEREOF | Cytosite Biopharma Inc. (US) | 2024-10-16 | — | — | EP | disclosed |
| US-20240228785-A1 | Fluorogenic pH-Sensitive Compounds and Their Methods of Use | Life Technologies Corporation | 2024-07-11 | — | — | US | disclosed |
| US-20240228785-A1 | Fluorogenic pH-Sensitive Compounds and Their Methods of Use | Life Technologies Corporation | 2024-07-11 | — | — | US | disclosed |
| WO-2024137729-A1 | NOVEL FAS RNAi THERAPEUTICS AND USES THEREOF | ELI LILLY AND COMPANY (US) | 2024-06-27 | — | — | WO | disclosed |
| EP-2888285-B1 | ANTIBODIES TO ARIPIPRAZOLE HAPTENS AND USE THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2024-04-17 | — | — | EP | disclosed |
| CN-117858948-A | Novel therapeutic agent delivery moieties and uses thereof | 伊莱利利公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-110054694-B | Antibodies to aripiprazole hapten and uses thereof | 詹森药业有限公司 | 2024-02-20 | — | — | CN | disclosed |
| US-20240010657-A1 | BIOTIN DERIVATIVES | Life Technologies Corporation | 2024-01-11 | — | — | US | disclosed |
| EP-3556759-B1 | HAPTENS OF PALIPERIDONE | JANSSEN PHARMACEUTICA NV (BE) | 2023-11-29 | — | — | EP | disclosed |
| US-11731982-B2 | Biotin derivatives | Life Technologies Corporation | 2023-08-22 | — | — | US | disclosed |
| US-11731982-B2 | Biotin derivatives | Life Technologies Corporation | 2023-08-22 | — | — | US | disclosed |
| US-11731982-B2 | Biotin derivatives | Life Technologies Corporation | 2023-08-22 | — | — | US | disclosed |
| WO-2023108031-A1 | PRODRUGS FOR COMPOUNDS SPECIFIC TO GRANZYME B AND USES THEREOF | CYTOSITE BIOPHARMA INC. (US) | 2023-06-15 | — | — | WO | disclosed |
| EP-2888284-B1 | ANTIBODIES TO RISPERIDONE HAPTENS AND USE THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2022-07-06 | — | — | EP | disclosed |
| CN-109970637-B | Aripiprazole hapten and application thereof in immunoassay | 詹森药业有限公司 | 2022-04-19 | — | — | CN | disclosed |
| CN-108484496-B | Aripiprazole hapten and application thereof in immunoassay | 詹森药业有限公司 | 2022-03-22 | — | — | CN | disclosed |
| US-11226345-B2 | Antibodies to olanzapine haptens and use thereof | JANSSEN PHARMACEUTICA NV (BE) | 2022-01-18 | — | — | US | disclosed |
| US-11225527-B2 | Antibodies to paliperidone haptens and use thereof | JANSSEN PHARMACEUTICA NV (BE) | 2022-01-18 | — | — | US | disclosed |
| EP-3415516-B1 | HAPTENS OF RISPERIDONE AND PALIPERIDONE | JANSSEN PHARMACEUTICA NV (BE) | 2021-12-15 | — | — | EP | disclosed |
| US-20210017294-A9 | ANTIBODIES TO QUETIAPINE HAPTENS AND USE THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2021-01-21 | — | — | US | disclosed |
| US-20200399400-A1 | ANTIBODIES TO RISPERIDONE HAPTENS AND USE THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2020-12-24 | — | — | US | disclosed |
| US-10793644-B2 | Antibodies to risperidone haptens and use thereof | JANSSEN PHARMACEUTICA NV (BE) | 2020-10-06 | — | — | US | disclosed |
| EP-3305784-B1 | HAPTENS OF QUETIAPINE FOR USE IN IMMUNOASSAYS | JANSSEN PHARMACEUTICA NV (BE) | 2020-08-12 | — | — | EP | disclosed |
| EP-3321254-B1 | HAPTENS OF ARIPIPRAZOLE AND THEIR USE IN IMMUNOASSAYS | JANSSEN PHARMACEUTICA NV (BE) | 2020-08-12 | — | — | EP | disclosed |
| US-10712353-B2 | Antibodies to olanzapine haptens and use thereof | JANSSEN PHARMACEUTICA NV (BE) | 2020-07-14 | — | — | US | disclosed |
| EP-3663317-A1 | ANTIBODIES TO QUETIAPINE HAPTENS AND USE THEREOF | Janssen Pharmaceutica NV (BE) | 2020-06-10 | — | — | EP | disclosed |
| CN-107266432-B | Quetiapine haptens for immunoassays | 詹森药业有限公司 | 2020-05-12 | — | — | CN | disclosed |
| EP-3385284-B1 | ANTIBODIES TO QUETIAPINE HAPTENS AND USE THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2020-02-26 | — | — | EP | disclosed |
| US-10570250-B2 | Dibenzosilole monomers and polymers and methods for their preparation and use | Life Technologies Corporation (US) | 2020-02-25 | — | — | US | disclosed |
| US-20200040107-A1 | ANTIBODIES TO QUETIAPINE HAPTENS AND USE THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2020-02-06 | — | — | US | disclosed |
| US-20190338047-A1 | Antibodies to Paliperidone Haptens and Use Thereof | JANSSEN PHARMACEUTICA NV (BE) | 2019-11-07 | — | — | US | disclosed |
| US-10465013-B2 | Antibodies to quetiapine haptens and use thereof | JANSSEN PHARMACEUTICA NV (BE) | 2019-11-05 | — | — | US | disclosed |
| US-20190331663-A1 | Antibodies to Aripiprazole Haptens and Use Thereof | JANSSEN PHARMACEUTICA NV (BE) | 2019-10-31 | — | — | US | disclosed |
| US-20190322681-A1 | Biotin Derivatives | LIFE TECHNOLOGIES AS (NO) | 2019-10-24 | — | — | US | disclosed |
| US-20190322681-A1 | Biotin Derivatives | LIFE TECHNOLOGIES AS (NO) | 2019-10-24 | — | — | US | disclosed |
| EP-3556759-A1 | HAPTENS OF PALIPERIDONE | Janssen Pharmaceutica NV (BE) | 2019-10-23 | — | — | EP | disclosed |
| US-10379105-B2 | Antibodies to aripiprazole haptens and use thereof | JANSSEN PHARMACEUTICA NV (BE) | 2019-08-13 | — | — | US | disclosed |
| US-10370457-B2 | Antibodies to paliperidone haptens and use thereof | JANSSEN PHARMACEUTICA NV (BE) | 2019-08-06 | — | — | US | disclosed |
| CN-110003201-A | Paliperidone haptens | 詹森药业有限公司 | 2019-07-12 | — | — | CN | disclosed |
| EP-3502693-A1 | CELL TRACKING REAGENTS AND THEIR METHODS OF USE | Life Technologies Corporation (US) | 2019-06-26 | — | — | EP | disclosed |
| EP-2888258-B1 | HAPTENS OF PALIPERIDONE | JANSSEN PHARMACEUTICA NV (BE) | 2019-06-05 | — | — | EP | disclosed |
| EP-3492473-A1 | HAPTENS OF OLANZIPINE | Janssen Pharmaceutica NV (BE) | 2019-06-05 | — | — | EP | disclosed |
| EP-2887952-B1 | ANTIBODIES TO OLANZAPINE HAPTENS AND USE THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2019-05-15 | — | — | EP | disclosed |
| US-10166296-B2 | Haptens of aripiprazole | JANSSEN PHARMACEUTICA NV (BE) | 2019-01-01 | — | — | US | disclosed |
| EP-3415516-A1 | HAPTENS OF RISPERIDONE AND PALIPERIDONE | Janssen Pharmaceutica NV (BE) | 2018-12-19 | — | — | EP | disclosed |
| US-20180355098-A1 | DIBENZOSILOLE MONOMERS AND POLYMERS AND METHODS FOR THEIR PREPARATION AND USE | Life Technologies Corporation | 2018-12-13 | — | — | US | disclosed |
| EP-2888269-B1 | HAPTENS OF OLANZAPINE | JANSSEN PHARMACEUTICA NV (BE) | 2018-10-24 | — | — | EP | disclosed |
| EP-3385284-A1 | ANTIBODIES TO QUETIAPINE HAPTENS AND USE THEREOF | Janssen Pharmaceutica NV (BE) | 2018-10-10 | — | — | EP | disclosed |
| US-10087280-B2 | Dibenzosilole monomers and polymers and methods for their preparation and use | Life Technologies Corporation (US) | 2018-10-02 | — | — | US | disclosed |
| US-20180149637-A1 | ANTIBODIES TO ARIPIPRAZOLE HAPTENS AND USE THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2018-05-31 | — | — | US | disclosed |
| EP-3321254-A1 | HAPTENS OF ARIPIPRAZOLE AND THEIR USE IN IMMUNOASSAYS | Janssen Pharmaceutica NV (BE) | 2018-05-16 | — | — | EP | disclosed |
| EP-2888263-B1 | HAPTENS OF RISPERIDONE AND PALIPERIDONE | JANSSEN PHARMACEUTICA NV (BE) | 2018-05-09 | — | — | EP | disclosed |
| US-20180117169-A1 | HAPTENS OF ARIPIPRAZOLE | JANSSEN PHARMACEUTICA NV (BE) | 2018-05-03 | — | — | US | disclosed |
| US-20180105606-A1 | ANTIBODIES TO QUETIAPINE HAPTENS AND USE THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2018-04-19 | — | — | US | disclosed |
| EP-3305784-A1 | HAPTENS OF QUETIAPINE FOR USE IN IMMUNOASSAYS | Janssen Pharmaceutica NV (BE) | 2018-04-11 | — | — | EP | disclosed |
| EP-2888286-B1 | ANTIBODIES TO QUETIAPINE HAPTENS AND USE THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2018-02-21 | — | — | EP | disclosed |
| US-20180022827-A1 | ANTIBODIES TO RISPERIDONE HAPTENS AND USE THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2018-01-25 | — | — | US | disclosed |
| EP-2633062-B1 | BIOTIN DERIVATIVES | LIFE TECHNOLOGIES CORP (US) | 2017-12-27 | — | — | EP | disclosed |
| EP-2633062-B1 | BIOTIN DERIVATIVES | LIFE TECHNOLOGIES CORP (US) | 2017-12-27 | — | — | EP | disclosed |
| US-9850318-B2 | Antibodies to quetiapine haptens and use thereof | JANSSEN PHARMACEUTICA NV (BE) | 2017-12-26 | — | — | US | disclosed |
| EP-2888234-B1 | HAPTENS OF ARIPIPRAZOLE AND THEIR USE IN IMMUNOASSAYS | JANSSEN PHARMACEUTICA NV (BE) | 2017-12-06 | — | — | EP | disclosed |
| US-20170343569-A1 | ANTIBODIES TO OLANZAPINE HAPTENS AND USE THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2017-11-30 | — | — | US | disclosed |
| US-9795685-B2 | Haptens of aripiprazole | JANSSEN PHARMACEUTICA NV (BE) | 2017-10-24 | — | — | US | disclosed |
| US-20170298147-A1 | ANTIBODIES TO PALIPERIDONE HAPTENS AND USE THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2017-10-19 | — | — | US | disclosed |
| EP-3215515-A1 | DIBENZOSILOLE MONOMERS AND POLYMERS AND METHODS FOR THEIR PREPARATION AND USE | Life Technologies Corporation (US) | 2017-09-13 | — | — | EP | disclosed |
| US-9751953-B2 | Antibodies to risperidone haptens and use thereof | JANSSEN PHARMACEUTICA NV (BE) | 2017-09-05 | — | — | US | disclosed |
| US-20170247504-A1 | DIBENZOSILOLE MONOMERS AND POLYMERS AND METHODS FOR THEIR PREPARATION AND USE | Life Technologies Corporation | 2017-08-31 | — | — | US | disclosed |
| US-20170240653-A1 | ANTIBODIES TO OLANZAPINE HAPTENS AND USE THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2017-08-24 | — | — | US | disclosed |
| EP-2888257-B1 | HAPTENS OF QUETIAPINE FOR USE IN IMMUNOASSAYS | JANSSEN PHARMACEUTICA NV (BE) | 2017-08-02 | — | — | EP | disclosed |
| US-20170204198-A1 | Antibodies to Aripiprazole Haptens and Use Thereof | JANSSEN PHARMACEUTICA NV (BE) | 2017-07-20 | — | — | US | disclosed |
| US-20170174700-A1 | Biotin Derivatives | Life Technologies Corporation | 2017-06-22 | — | — | US | disclosed |
| US-20170129968-A1 | ANTIBODIES TO PALIPERIDONE HAPTENS AND USE THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2017-05-11 | — | — | US | disclosed |
| US-9611332-B2 | Antibodies to aripiprazole haptens and use thereof | JANSSEN PHARMACEUTICA NV (BE) | 2017-04-04 | — | — | US | disclosed |
| EP-3143400-A1 | CELL TRACKING REAGENTS AND THEIR METHODS OF USE | Life Technologies Corporation (US) | 2017-03-22 | — | — | EP | disclosed |
| US-20170072061-A1 | HAPTENS OF ARIPIPRAZOLE | JANSSEN PHARMACEUTICA NV (BE) | 2017-03-16 | — | — | US | disclosed |
| US-20170044372-A1 | CELL TRACKING REAGENTS AND THEIR METHODS OF USE | Life Technologies Corporation | 2017-02-16 | — | — | US | disclosed |
| US-9567346-B2 | Biotin derivatives | Life Technologies Corporation (US) | 2017-02-14 | — | — | US | disclosed |
| US-9567346-B2 | Biotin derivatives | Life Technologies Corporation (US) | 2017-02-14 | — | — | US | disclosed |
| US-9567346-B2 | Biotin derivatives | Life Technologies Corporation (US) | 2017-02-14 | — | — | US | disclosed |
| US-9513284-B2 | Pyrenyloxysulfonic acid fluorescent agents | Life Technologies Corporation (US) | 2016-12-06 | — | — | US | disclosed |
| US-20160346409-A1 | TARGETED MOLECULAR IMAGING CONTRAST AGENTS | UNIV MCMASTER (CA) | 2016-12-01 | — | — | US | disclosed |
| US-9504682-B2 | Haptens of aripiprazole | JANSSEN PHARMACEUTICA NV (BE) | 2016-11-29 | — | — | US | disclosed |
| US-9394354-B2 | Haptens of paliperidone | JANSSEN PHARMACEUTICA NV (BE) | 2016-07-19 | — | — | US | disclosed |
| WO-2016073052-A1 | DIBENZOSILOLE MONOMERS AND POLYMERS AND METHODS FOR THEIR PREPARATION AND USE | Life Technologies Corporation (US) | 2016-05-12 | — | — | WO | disclosed |
| US-9304126-B2 | Haptens of quetiapine | JANSSEN PHARMACEUTICA NV (BE) | 2016-04-05 | — | — | US | disclosed |
| US-9303041-B2 | Haptens of olanzapine | JANSSEN PHARMACEUTICA NV (BE) | 2016-04-05 | — | — | US | disclosed |
| WO-2015175873-A1 | CELL TRACKING REAGENTS AND THEIR METHODS OF USE | Life Technologies Corporation (US) | 2015-11-19 | — | — | WO | disclosed |
| WO-2015117235-A1 | TARGETED MOLECULAR IMAGING CONTRAST AGENTS | MCMASTER UNIVERSITY (CA) | 2015-08-13 | — | — | WO | disclosed |
| EP-2887952-A1 | ANTIBODIES TO OLANZAPINE HAPTENS AND USE THEREOF | ORTHO-CLINICAL DIAGNOSTICS, INC. (US) | 2015-07-01 | — | — | EP | disclosed |
| EP-2888258-A1 | HAPTENS OF PALIPERIDONE | Janssen Pharmaceutica, N.V. (BE) | 2015-07-01 | — | — | EP | disclosed |
| EP-2888284-A1 | ANTIBODIES TO RISPERIDONE HAPTENS AND USE THEREOF | ORTHO-CLINICAL DIAGNOSTICS, INC. (US) | 2015-07-01 | — | — | EP | disclosed |
| EP-2888286-A1 | ANTIBODIES TO QUETIAPINE HAPTENS AND USE THEREOF | Ortho-Clinical Diagnostics Inc (US) | 2015-07-01 | — | — | EP | disclosed |
| EP-2888285-A1 | ANTIBODIES TO ARIPIPRAZOLE HAPTENS AND USE THEREOF | ORTHO-CLINICAL DIAGNOSTICS, INC. (US) | 2015-07-01 | — | — | EP | disclosed |
| EP-2888234-A1 | HAPTENS OF ARIPIPRAZOLE AND THEIR USE IN IMMUNOASSAYS | Janssen Pharmaceutica, N.V. (BE) | 2015-07-01 | — | — | EP | disclosed |
| EP-2888287-A1 | ANTIBODIES TO PALIPERIDONE HAPTENS AND USE THEREOF | ORTHO-CLINICAL DIAGNOSTICS, INC. (US) | 2015-07-01 | — | — | EP | disclosed |
| US-9012648-B2 | Haptens of risperidone and paliperidone | JANSSEN PHARMACEUTICA NV (BE) | 2015-04-21 | — | — | US | disclosed |
| US-20140221616-A1 | HAPTENS OF QUETIAPINE | ORTHO-CLINICAL DIAGNOSTICS, INC. (US) | 2014-08-07 | — | — | US | disclosed |
| US-20140213767-A1 | HAPTENS OF PALIPERIDONE | ORTHO-CLINICAL DIAGNOSTICS, INC. (US) | 2014-07-31 | — | — | US | disclosed |
| US-20140213766-A1 | HAPTENS OF OLANZIPINE | ORTHO-CLINICAL DIAGNOSTICS, INC. (US) | 2014-07-31 | — | — | US | disclosed |
| US-20140193926-A1 | PYRENYLOXYSULFONIC ACID FLUORESCENT AGENTS | Life Technologies Corporation (US) | 2014-07-10 | — | — | US | disclosed |
| US-20140163206-A1 | HAPTENS OF ARIPIPRAZOLE | ORTHO-CLINICAL DIAGNOSTICS, INC. (US) | 2014-06-12 | — | — | US | disclosed |
| US-20140155585-A1 | HAPTENS OF RISPERIDONE AND PALIPERIDONE | ORTHO-CLINICAL DIAGNOSTICS, INC. (US) | 2014-06-05 | — | — | US | disclosed |
| EP-1520177-B1 | METHOD AND REAGENT FOR SPECIFICALLY IDENTIFYING AND QUANTIFYING ONE OR MORE PROTEINS IN A SAMPLE | PROTEOME FACTORY AG (DE) | 2014-05-07 | — | — | EP | disclosed |
| US-20140057301-A1 | Antibodies to Risperidone Haptens and Use Thereof | JANSSEN PHARMACEUTICA NV (BE) | 2014-02-27 | — | — | US | disclosed |
| US-20140057299-A1 | Antibodies to Aripiprazole Haptens and Use Thereof | JANSSEN PHARMACEUTICA NV (BE) | 2014-02-27 | — | — | US | disclosed |
| WO-2014031635-A1 | ANTIBODIES TO ARIPIPRAZOLE HAPTENS AND USE THEREOF | ORTHO-CLINICAL DIAGNOSTICS, INC (US) | 2014-02-27 | — | — | WO | disclosed |
| WO-2014031665-A1 | ANTIBODIES TO QUETIAPINE HAPTENS AND USE THEREOF | ORTHO-CLINICAL DIAGNOSTICS, INC (US) | 2014-02-27 | — | — | WO | disclosed |
| US-20140057305-A1 | Antibodies to Quetiapine Haptens and Use Thereof | JANSSEN PHARMACEUTICA NV (BE) | 2014-02-27 | — | — | US | disclosed |
| WO-2014031656-A1 | ANTIBODIES TO OLANZAPINE HAPTENS AND USE THEREOF | ORTHO-CLINICAL DIAGNOSTICS, INC (US) | 2014-02-27 | — | — | WO | disclosed |
| US-20140057303-A1 | Antibodies to Olanzapine Haptens and Use Thereof | JANSSEN PHARMACEUTICA NV (BE) | 2014-02-27 | — | — | US | disclosed |
| WO-2014031584-A1 | HAPTENS OF ARIPIPRAZOLE AND THEIR USE IN IMMUNOASSAYS | JANSSEN PHARMACEUTICA NV (BE) | 2014-02-27 | — | — | WO | disclosed |
| US-20140057297-A1 | Antibodies to Paliperidone Haptens and Use Thereof | JANSSEN PHARMACEUTICA NV (BE) | 2014-02-27 | — | — | US | disclosed |
| WO-2014031595-A1 | HAPTENS OF PALIPERIDONE | JANSSEN PHARMACEUTICA NV (BE) | 2014-02-27 | — | — | WO | disclosed |
| WO-2014031645-A1 | ANTIBODIES TO RISPERIDONE HAPTENS AND USE THEREOF | ORTHO-CLINICAL DIAGNOSTICS, INC (US) | 2014-02-27 | — | — | WO | disclosed |
| WO-2014031603-A1 | ANTIBODIES TO PALIPERIDONE HAPTENS AND USE THEREOF | ORTHO-CLINICAL DIAGNOSTICS, INC (US) | 2014-02-27 | — | — | WO | disclosed |
| US-20140017797-A1 | PROTEIN AFFINITY TAG AND USES THEREOF | De Staadt der Nederlanden, vert doorde minister van VWS (NL) | 2014-01-16 | — | — | US | disclosed |
| US-20140011255-A1 | Biotin Derivatives | Life Technologies Corporation (US) | 2014-01-09 | — | — | US | disclosed |
| US-20140011255-A1 | Biotin Derivatives | Life Technologies Corporation (US) | 2014-01-09 | — | — | US | disclosed |
| US-20140011255-A1 | Biotin Derivatives | Life Technologies Corporation (US) | 2014-01-09 | — | — | US | disclosed |
| US-8614294-B2 | Pyrenyloxysulfonic acid fluorescent agents | Life Technologies Corporation (US) | 2013-12-24 | — | — | US | disclosed |
| EP-2651961-A1 | PROTEIN AFFINITY TAG AND USES THEREOF | De Staat Der Nederlanden, Vert. Door De Minister Van VWS (NL) | 2013-10-23 | — | — | EP | disclosed |
| EP-1684810-B1 | Polybiotin compounds for magnetic resonance imaging and drug delivery | GEN HOSPITAL CORP (US) | 2013-09-25 | — | — | EP | disclosed |
| CN-103298949-A | Biotin derivatives | LIFE TECHNOLOGIES CORP | 2013-09-11 | — | — | CN | disclosed |
| EP-2633062-A1 | BIOTIN DERIVATIVES | Life Technologies Corporation (US) | 2013-09-04 | — | — | EP | disclosed |
| US-8465921-B2 | Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders | ELITECH HOLDING B.V. (NL) | 2013-06-18 | — | — | US | disclosed |
| US-8435800-B2 | Activated labeling reagents and methods for preparing and using the same | BIOSIGHT LTD. (IL) | 2013-05-07 | — | — | US | disclosed |
| US-20130079497-A1 | PYRENYLOXYSULFONIC ACID FLUORESCENT AGENTS | Life Technologies Corporation (US) | 2013-03-28 | — | — | US | disclosed |
| US-8268886-B2 | Pyrenyloxysulfonic acid fluorescent agents | Life Technologies Corporation (US) | 2012-09-18 | — | — | US | disclosed |
| WO-2012081978-A1 | PROTEIN AFFINITY TAG AND USES THEREOF | DE STAAT DER NEDERLANDEN, VERT. DOOR DE MINISTER VAN VWS (NL) | 2012-06-21 | — | — | WO | disclosed |
| WO-2012034613-A3 | REFRIGERATOR | RED BULL GMBH (AT) | 2012-05-10 | — | — | WO | disclosed |
| WO-2012058635-A1 | BIOTIN DERIVATIVES | Life Technologies Corporation (US) | 2012-05-03 | — | — | WO | disclosed |
| WO-2012058635-A1 | BIOTIN DERIVATIVES | Life Technologies Corporation (US) | 2012-05-03 | — | — | WO | disclosed |
| US-8124364-B2 | Biotin derivatives | GLYCOREX TRANSPLANTATION AB (SE) | 2012-02-28 | — | — | US | disclosed |
| US-8124364-B2 | Biotin derivatives | GLYCOREX TRANSPLANTATION AB (SE) | 2012-02-28 | — | — | US | disclosed |
| US-8124364-B2 | Biotin derivatives | GLYCOREX TRANSPLANTATION AB (SE) | 2012-02-28 | — | — | US | disclosed |
| US-20120045848-A1 | PYRENYLOXYSULFONIC ACID FLUORESCENT AGENTS | Life Technologies Corporation (US) | 2012-02-23 | — | — | US | disclosed |
| US-8097463-B2 | Use of arylboronic acids in protein labelling | KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) | 2012-01-17 | — | — | US | disclosed |
| US-8092782-B2 | Polybiotin compounds of magnetic resonance imaging and drug delivery | THE GENERAL HOSPITAL CORPORATION (US) | 2012-01-10 | — | — | US | disclosed |
| EP-1329513-B1 | Rapid quantitative analysis of proteins or protein function in complex mixtures | UNIV WASHINGTON (US) | 2011-12-07 | — | — | EP | disclosed |
| US-20110275070-A1 | HYBRIDIZATION AND MISMATCH DISCRIMINATION USING OLIGONUCLEOTIDES CONJUGATED TO MINOR GROOVE BINDERS | EPOCH PHARMACEUTICALS, INC. | 2011-11-10 | — | — | US | disclosed |
| US-8039642-B2 | Pyrenyloxysulfonic acid fluorescent agents | Life Technologies Corporation (US) | 2011-10-18 | — | — | US | disclosed |
| US-20110217727-A1 | METHOD FOR PATTERNING MAGNETIC MATERIALS IN LIVE CELL, METHOD FOR IMAGING PATTERN OF MAGNETIC MATERIALS, AND APPARATUS USED FOR SAME | MEDISCOV INC. (KR) | 2011-09-08 | — | — | US | disclosed |
| CN-101914099-A | Covalently linked oligonucleotide minor groove binder conjugates | EPOCH BIOSCIENCES INC | 2010-12-15 | — | — | CN | disclosed |
| US-7794945-B2 | Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders | ELITECH HOLDING B.V. (NL) | 2010-09-14 | — | — | US | disclosed |
| US-20100167262-A1 | METHOD AND REAGENT FOR THE SPECIFIC IDENTIFICATION AND QUANTIFICATION OF ONE OR MORE PROTEINS IN A SAMPLE USING IN PARTICULAR INDUCTIVELY COUPLED PLASMA-MASS SPECTROMETRY | PROTEOME FACTORY AG (DE) | 2010-07-01 | — | — | US | disclosed |
| EP-1289563-B1 | METHOD FOR CONDITIONING AN AVIDIN OR STREPTAVIDIN COLUMN MATRIX IN AN EXTRACORPOREAL DEVICE | MITRA MEDICAL TECHNOLOGY AB (SE) | 2010-06-02 | — | — | EP | disclosed |
| US-20100068819-A1 | COMPOUNDS AND METHODS FOR DOUBLE LABELLING OF POLYPEPTIDES TO ALLOW MULTIPLEXING IN MASS SPECTROMETRIC ANALYSIS | KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) | 2010-03-18 | — | — | US | disclosed |
| US-20100041162-A1 | USE OF ARYLBORONIC ACIDS IN PROTEIN LABELLING | KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) | 2010-02-18 | — | — | US | disclosed |
| EP-1105517-B2 | RAPID QUANTITATIVE ANALYSIS OF PROTEINS OR PROTEIN FUNCTION IN COMPLEX MIXTURES | UNIV WASHINGTON (US) | 2009-09-30 | — | — | EP | disclosed |
| US-20090203879-A1 | ACTIVATED LABELING REAGENTS AND METHODS FOR PREPARING AND USING THE SAME | BIOSIGHT LTD | 2009-08-13 | — | — | US | disclosed |
| EP-2086984-A1 | USE OF ARYLBORONIC ACIDS IN PROTEIN LABELLING | Philips Intellectual Property & Standards GmbH (DE) | 2009-08-12 | — | — | EP | disclosed |
| EP-2087357-A1 | COMPOUNDS AND METHODS FOR DOUBLE LABELLING OF POLYPEPTIDES TO ALLOW MULTIPLEXING IN MASS SPECTROMETRIC ANALYSIS | Koninklijke Philips Electronics N.V. (NL) | 2009-08-12 | — | — | EP | disclosed |
| EP-1144429-B1 | HYBRIDIZATION AND MISMATCH DISCRIMINATION USING OLIGONUCLEOTIDES CONJUGATED TO MINOR GROOVE BINDERS | EPOCH BIOSCIENCES INC (US) | 2009-07-15 | — | — | EP | disclosed |
| US-7556923-B1 | Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders | EPOCH BIOSCIENCES, INC. (US) | 2009-07-07 | — | — | US | disclosed |
| EP-1814908-A4 | ACTIVATED LABELING REAGENTS AND METHODS FOR PREPARING AND USING THE SAME | BIOSIGHT LTD (IL) | 2009-07-01 | — | — | EP | disclosed |
| US-7544518-B2 | Rapid quantitative analysis of proteins or protein function in complex mixtures | UNIVERSITY OF WASHINGTON (US) | 2009-06-09 | — | — | US | disclosed |
| US-7544518-B2 | Rapid quantitative analysis of proteins or protein function in complex mixtures | UNIVERSITY OF WASHINGTON (US) | 2009-06-09 | — | — | US | disclosed |
| US-7544518-B2 | Rapid quantitative analysis of proteins or protein function in complex mixtures | UNIVERSITY OF WASHINGTON (US) | 2009-06-09 | — | — | US | disclosed |
| EP-1684810-A4 | POLYBIOTIN COMPOUNDS FOR MAGNETIC RESONANCE IMAGINING AND DRUG DELIVERY | GEN HOSPITAL CORP (US) | 2009-05-27 | — | — | EP | disclosed |
| US-20090053742-A1 | Capture and release based isotope tagged peptides and methods for using the same | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2009-02-26 | — | — | US | disclosed |
| US-20090048427-A1 | HYBRIDIZATION AND MISMATCH DISCRIMINATION USING OLIGONUCLEOTIDES CONJUGATED TO MINOR GROOVE BINDERS | EPOCH BIOSCIENCES, INC. (US) | 2009-02-19 | — | — | US | disclosed |
| US-20090010845-A1 | Polybiotin Compounds of Magnetic Resonance Imaging and Drug Delivery | THE GENERAL HOSPITAL CORPORATION (US) | 2009-01-08 | — | — | US | disclosed |
| EP-2008109-A1 | METHOD AND REAGENT FOR THE SPECIFIC IDENTIFICATION AND QUANTIFICATION OF ONE OR MORE PROTEINS IN A SAMPLE USING INDUCTIVELY COUPLED PLASMA-MASS SPECTROMETRY | Proteome Factory AG (DE) | 2008-12-31 | — | — | EP | disclosed |
| US-7438893-B2 | Polybiotin compounds for magnetic resonance imaging and drug delivery | MASSACHUSETTS GENERAL HOSPITAL (US) | 2008-10-21 | — | — | US | disclosed |
| US-7425451-B2 | Triazine derivatives as universal peptide isotope tag reagents (U-PIT) | AGILENT TECHNOLOGIES, INC. (US) | 2008-09-16 | — | — | US | disclosed |
| WO-2008056290-A9 | USE OF ARYLBORONIC ACIDS IN PROTEIN LABELLING | PHILIPS INTELLECTUAL PROPERTY (DE) | 2008-09-12 | — | — | WO | disclosed |
| EP-1631553-A4 | CAPTURE AND RELEASE BASED ISOTOPE TAGGED PEPTIDES AND METHODS FOR USING THE SAME | HARVARD COLLEGE (US) | 2008-09-10 | — | — | EP | disclosed |
| WO-2008056290-A1 | USE OF ARYLBORONIC ACIDS IN PROTEIN LABELLING | PHILIPS INTELLECTUAL PROPERTY & STANDARDS GMBH (DE) | 2008-05-15 | — | — | WO | disclosed |
| EP-1921081-A1 | Use of arylboronic acids in protein labelling | Koninklijke Philips Electronics N.V. (NL) | 2008-05-14 | — | — | EP | disclosed |
| WO-2008053399-A1 | COMPOUNDS AND METHODS FOR DOUBLE LABELLING OF POLYPEPTIDES TO ALLOW MULTIPLEXING IN MASS SPECTROMETRIC ANALYSIS | KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) | 2008-05-08 | — | — | WO | disclosed |
| EP-1918714-A1 | Compounds and methods for double labelling of polypeptides to allow multiplexing in mass spectrometric analysis | Koninklijke Philips Electronics N.V. (NL) | 2008-05-07 | — | — | EP | disclosed |
| EP-1916526-A1 | Method for diagnostic and therapeutic target discovery by combining isotopic and isobaric labels | Koninklijke Philips Electronics N.V. (NL) | 2008-04-30 | — | — | EP | disclosed |
| US-20080081343-A1 | Differential labeling for quantitative analysis of complex protein mixtures | SYNGENTA PARTICIPATIONS AG (CH) | 2008-04-03 | — | — | US | disclosed |
| US-7332613-B2 | Capture and release based isotope tagged peptides and methods for using the same | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2008-02-19 | — | — | US | disclosed |
| US-20080032379-A1 | PYRENYLOXYSULFONIC ACID FLURESCENT AGENTS | INVITROGEN CORPORATION (US) | 2008-02-07 | — | — | US | disclosed |
| EP-0819133-B1 | COVALENTLY LINKED OLIGONUCLEOTIDE MINOR GROOVE BINDER CONJUGATES | EPOCH BIOSCIENCES INC (US) | 2008-01-02 | — | — | EP | disclosed |
| US-7297495-B2 | Hybridization-triggered fluorescent detection of nucleic acids | EPOCH BIOSCIENCES, INC. (US) | 2007-11-20 | — | — | US | disclosed |
| WO-2007118712-A1 | METHOD AND REAGENT FOR THE SPECIFIC IDENTIFICATION AND QUANTIFICATION OF ONE OR MORE PROTEINS IN A SAMPLE USING INDUCTIVELY COUPLED PLASMA-MASS SPECTROMETRY | PROTEOME FACTORY AG (DE) | 2007-10-25 | — | — | WO | disclosed |
| EP-1814908-A1 | ACTIVATED LABELING REAGENTS AND METHODS FOR PREPARING AND USING THE SAME | Biosight Ltd. (IL) | 2007-08-08 | — | — | EP | disclosed |
| US-20070166723-A1 | Hybridization-triggered fluorescent detection of nucleic acids | EPOCH BIOSCIENCES INC. (US) | 2007-07-19 | — | — | US | disclosed |
| US-7175986-B2 | Methods and reagents for differential proteomic analysis | PROTEOMYX INC. (US) | 2007-02-13 | — | — | US | disclosed |
| US-20070031973-A1 | Triazine derivatives as universal peptide isotope tag reagents (U-PIT) | ROBOTTI KARLA M | 2007-02-08 | — | — | US | disclosed |
| US-7166436-B2 | Differential labeling for quantitative analysis of complex protein mixtures | SYNGENTA PARTICIPATIONS, AG (CH) | 2007-01-23 | — | — | US | disclosed |
| EP-1392848-B1 | PROCESS FOR ANALYZING PROTEIN SAMPLES | PERSEPTIVE BIOSYSTEMS INC (US) | 2007-01-03 | — | — | EP | disclosed |
| US-7141676-B1 | Water soluble multi-biotin-containing compounds | UNIVERSITY OF WASHINGTON (US) | 2006-11-28 | — | — | US | disclosed |
| US-20060246530-A1 | Method and reagent for the specifically identifying and quantifying one or more proteins in a sample | PROTEOME FACTORY AG (DE) | 2006-11-02 | — | — | US | disclosed |
| US-20060228325-A1 | Water soluble multi-biotin-containing compounds | WILBUR D S | 2006-10-12 | — | — | US | disclosed |
| EP-1684810-A1 | POLYBIOTIN COMPOUNDS FOR MAGNETIC RESONANCE IMAGINING AND DRUG DELIVERY | THE GENERAL HOSPITAL CORPORATION (US) | 2006-08-02 | — | — | EP | disclosed |
| US-7052915-B2 | Useful for the detection of phosphoproteins; amidating carboxy groups and forming phosphoramidates with phosphate groups, selectively deprotecting the phosphoramide group and reacting free phosphate groups | UNIVERSITY OF WASHINGTON (US) | 2006-05-30 | — | — | US | disclosed |
| WO-2006054310-A1 | ACTIVATED LABELING REAGENTS AND METHODS FOR PREPARING AND USING THE SAME | BIOSIGHT LTD. (IL) | 2006-05-26 | — | — | WO | disclosed |
| US-7045296-B2 | Process for analyzing protein samples | APPLERA CORPORATION (US) | 2006-05-16 | — | — | US | disclosed |
| EP-1428019-A4 | SYSTEM AND METHOD OF DETERMINING PROTEOMIC DIFFERENCES | SYNGENTA PARTICIPATIONS AG (CH) | 2006-04-26 | — | — | EP | disclosed |
| EP-1631553-A2 | CAPTURE AND RELEASE BASED ISOTOPE TAGGED PEPTIDES AND METHODS FOR USING THE SAME | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2006-03-08 | — | — | EP | disclosed |
| US-20060004525-A1 | System and method of determining proteomic differences | SYNGENTA PARTICIPATIONS AG | 2006-01-05 | — | — | US | disclosed |
| US-6969757-B2 | Differential labeling for quantitative analysis of complex protein mixtures | SYNGENTA PARTICIPATIONS AG (CH) | 2005-11-29 | — | — | US | disclosed |
| US-20050250957-A1 | Compounds containing thiosulfate moieties | MOLECULAR PROBES, INC | 2005-11-10 | — | — | US | disclosed |
| US-20050233399-A1 | Rapid quantitative analysis of proteins or protein function in complex mixtures | UNIVERSITY OF WASHINGTON | 2005-10-20 | — | — | US | disclosed |
| EP-1456227-B1 | NON-AFFINITY BASED ISOTOPE TAGGED PEPTIDES AND METHODS FOR USING THE SAME | HARVARD COLLEGE (US) | 2005-10-05 | — | — | EP | disclosed |
| US-6951930-B2 | Hybridization-triggered fluorescent detection of nucleic acids | EPOCH BIOSCIENCES, INC. (US) | 2005-10-04 | — | — | US | disclosed |
| WO-2005042559-A9 | CAPTURE AND RELEASE BASED ISOTOPE TAGGED PEPTIDES AND METHODS FOR USING THE SAME | HARVARD COLLEGE (US) | 2005-08-18 | — | — | WO | disclosed |
| CN-1644585-A | Covalently linked oligonucleotide minor grove binder conjugates | EPOCH PHARMACEUTICALS INC (US) | 2005-07-27 | — | — | CN | disclosed |
| WO-2005064336-A1 | PYRENYLOXYSULFONIC ACID FLUORESCENT AGENTS | MOLECULAR PROBES, INC. (US) | 2005-07-14 | — | — | WO | disclosed |
| US-20050136008-A1 | Polybiotin compounds for magnetic resonance imaging and drug delivery | MASSACHUSETTS GENERAL HOSPITAL (US) | 2005-06-23 | — | — | US | disclosed |
| EP-1392848-A4 | PROCESS FOR ANALYZING PROTEIN SAMPLES | PERSEPTIVE BIOSYSTEMS INC (US) | 2005-06-22 | — | — | EP | disclosed |
| US-20050123935-A1 | Pyrenyloxysulfonic acid fluorescent agents | MOLECULAR PROBES, INC. | 2005-06-09 | — | — | US | disclosed |
| WO-2005047242-A2 | COMPOUNDS CONTAINING THIOSULFATE MOIETIES | MOLECULAR PROBES, INC. (US) | 2005-05-26 | — | — | WO | disclosed |
| WO-2005042559-A2 | CAPTURE AND RELEASE BASED ISOTOPE TAGGED PEPTIDES AND METHODS FOR USING THE SAME | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2005-05-12 | — | — | WO | disclosed |
| EP-1525483-A2 | DIFFERENTIAL LABELING FOR QUANTITATIVE ANALYSIS OF COMPLEX PROTEIN MIXTURES BY TRIFUNCTIONAL SYNTHETIC PEPTIDE BASED REAGENTS WITH IODACETAMIDO GROUPS | Syngenta Participations AG (CH) | 2005-04-27 | — | — | EP | disclosed |
| US-6884584-B2 | Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders | EPOCH BIOSCIENCES, INC. (US) | 2005-04-26 | — | — | US | disclosed |
| WO-2005032598-A1 | POLYBIOTIN COMPOUNDS FOR MAGNETIC RESONANCE IMAGINING AND DRUG DELIVERY | THE GENERAL HOSPITAL CORPORATION (US) | 2005-04-14 | — | — | WO | disclosed |
| US-20050074794-A1 | Methods and reagents for differential proteomic analysis | TRAN NATHANIEL TUE (US) | 2005-04-07 | — | — | US | disclosed |
| EP-1520177-A2 | METHOD AND REAGENT FOR SPECIFICALLY IDENTIFYING AND QUANTIFYING ONE OR MORE PROTEINS IN A SAMPLE | Proteome Factory AG (DE) | 2005-04-06 | — | — | EP | disclosed |
| US-20050064463-A1 | Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders | DRUG ROYALTY LP1 (CA) | 2005-03-24 | — | — | US | disclosed |
| EP-1346229-B1 | INVERSE LABELING METHOD FOR THE RAPID IDENTIFICATION OF MARKER/TARGET PROTEINS | NOVARTIS AG (CH) | 2005-03-16 | — | — | EP | disclosed |
| US-6852544-B2 | Rapid quantitative analysis of proteins or protein function in complex mixtures | UNIVERSITY OF WASHINGTON (US) | 2005-02-08 | — | — | US | disclosed |
| EP-1295123-A4 | SELECTIVE LABELING AND ISOLATION OF PHOSPHOPEPTIDES AND APPLICATIONS TO PROTEOME ANALYSIS | UNIV WASHINGTON (US) | 2005-02-02 | — | — | EP | disclosed |
| CN-1187363-C | Covalently bound oligonucleotide minor groove binder conjugates | IBORCH PHARMACEUTICAL CORP (US) | 2005-02-02 | — | — | CN | disclosed |
| US-20040259164-A1 | Capture and release based isotope tagged peptides and methods for using the same | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2004-12-23 | — | — | US | disclosed |
| EP-1456227-A4 | NON-AFFINITY BASED ISOTOPE TAGGED PEPTIDES AND METHODS FOR USING THE SAME | HARVARD COLLEGE (US) | 2004-12-15 | — | — | EP | disclosed |
| US-20040235186-A1 | Non-affinity based isotope tagged peptides and methods for using the same | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2004-11-25 | — | — | US | disclosed |
| EP-1456227-A2 | NON-AFFINITY BASED ISOTOPE TAGGED PEPTIDES AND METHODS FOR USING THE SAME | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2004-09-15 | — | — | EP | disclosed |
| WO-2002059144-A9 | DIFFERENTIAL LABELING FOR QUANTITATIVE ANALYSIS OF COMPLEX PROTEIN MIXTURES | SYNGENTA PARTICIPATIONS AG (US) | 2004-08-12 | — | — | WO | disclosed |
| US-20040115821-A1 | Triazine derivatives as universal peptide isotope tag reagents (U-PIT) | AGILENT TECHNOLOGIES, INC. | 2004-06-17 | — | — | US | disclosed |
| EP-1429147-A1 | Universal reagent for isotopically tagging peptides | Agilent Technologies, Inc. (US) | 2004-06-16 | — | — | EP | disclosed |
| EP-1428019-A2 | SYSTEM AND METHOD OF DETERMINING PROTEOMIC DIFFERENCES | Syngenta Participations AG (CH) | 2004-06-16 | — | — | EP | disclosed |
| US-20040106150-A1 | Inverse labeling method for the rapid identification of marker/target proteins | WANG YINGQI KAREN (US) | 2004-06-03 | — | — | US | disclosed |
| WO-2003006951-A9 | SYSTEM AND METHOD OF DETERMINING PROTEOMIC DIFFERENCES | SYNGENTA PARTICIPATIONS AG (CH) | 2004-05-13 | — | — | WO | disclosed |
| US-20040058322-A1 | Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders | EPOCH PHARMACEUTICALS, INC. (US) | 2004-03-25 | — | — | US | disclosed |
| US-20040052784-A1 | Biotin derivatives | GLYCOREX TRANSPLANTATION AB (SE) | 2004-03-18 | — | — | US | disclosed |
| EP-1392848-A2 | PROCESS FOR ANALYZING PROTEIN SAMPLES | PerSeptive Biosystems, Inc. (US) | 2004-03-03 | — | — | EP | disclosed |
| WO-2004013636-A2 | DIFFERENTIAL LABELING FOR QUANTITATIVE ANALYSIS OF COMPLEX PROTEIN MIXTURES BY TRIFUNCTIONAL SYNTHETIC PEPTIDE BASED REAGENTS WITH IODOACETAMIDO GROUPS | SYNGENTA PARTICIPATIONS AG (CH) | 2004-02-12 | — | — | WO | disclosed |
| WO-2004001420-A2 | METHOD AND REAGENT FOR SPECIFICALLY IDENTIFYING AND QUANTIFYING ONE OR MORE PROTEINS IN A SAMPLE | PROTEOME FACTORY AG (DE) | 2003-12-31 | — | — | WO | disclosed |
| US-6670194-B1 | Mass spectrometry; screening for changes in the expression of enzymatic activity of specific proteins induced by absence, deficiency or excess of a given protein | UNIVERSITY OF WASHINGTON | 2003-12-30 | — | — | US | disclosed |
| EP-1105517-B1 | RAPID QUANTITATIVE ANALYSIS OF PROTEINS OR PROTEIN FUNCTION IN COMPLEX MIXTURES | UNIV WASHINGTON (US) | 2003-10-29 | — | — | EP | disclosed |
| EP-1346229-A2 | INVERSE LABELING METHOD FOR THE RAPID IDENTIFICATION OF MARKER/TARGET PROTEINS | Novartis AG (CH) | 2003-09-24 | — | — | EP | disclosed |
| EP-1329513-A1 | Rapid quantitative analysis of proteins or protein function in complex mixtures | UNIVERSITY OF WASHINGTON (US) | 2003-07-23 | — | — | EP | disclosed |
| US-20030113765-A1 | Hybridization-triggered fluorescent detection of nucleic acids | EPOCH BIOSCIENCES, INC. (US) | 2003-06-19 | — | — | US | disclosed |
| US-20030087329-A1 | Differential labeling for quantitative analysis of complex protein mixtures | SYNGENTA PARTICIPATIONS AG (CH) | 2003-05-08 | — | — | US | disclosed |
| US-20030087322-A9 | Rapid quantitative analysis of proteins or protein function in complex mixtures | UNIVERSITY OF WASHINGTON | 2003-05-08 | — | — | US | disclosed |
| US-20030082522-A1 | Differential labeling for quantitative analysis of complex protein mixtures | SYNGENTA PARTICIPATIONS AG (CH) | 2003-05-01 | — | — | US | disclosed |
| US-20030068825-A1 | System and method of determining proteomic differences | SYNGENTA PARTICIPATIONS AG (CH) | 2003-04-10 | — | — | US | disclosed |
| EP-1295123-A1 | SELECTIVE LABELING AND ISOLATION OF PHOSPHOPEPTIDES AND APPLICATIONS TO PROTEOME ANALYSIS | UNIVERSITY OF WASHINGTON (US) | 2003-03-26 | — | — | EP | disclosed |
| EP-1289563-A2 | BIOTIN DERIVATIVES | Mitra Medical Technology AB (SE) | 2003-03-12 | — | — | EP | disclosed |
| WO-2003008547-A2 | NON-AFFINITY BASED ISOTOPE TAGGED PEPTIDES AND METHODS FOR USING THE SAME | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2003-01-30 | — | — | WO | disclosed |
| WO-2003006951-A2 | SYSTEM AND METHOD OF DETERMINING PROTEOMIC DIFFERENCES | SYNGENTA PARTICIPATIONS AG (CH) | 2003-01-23 | — | — | WO | disclosed |
| US-20020192720-A1 | Process for analyzing protein samples | APPLIED BIOSYSTEMS, LLC | 2002-12-19 | — | — | US | disclosed |
| US-6492346-B1 | Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders | EPOCH PHARMACEUTICALS, INC. | 2002-12-10 | — | — | US | disclosed |
| US-6486308-B2 | NUCLEOTIDE SEQUENCE BINDING PARTICLES; FOR USE AS THERAPEUTIC AND DIAGNOSTIC TOOLS | EPOCH BIOSCIENCES, INC. | 2002-11-26 | — | — | US | disclosed |
| WO-2002090929-A2 | PROCESS FOR ANALYZING PROTEIN SAMPLES | PERSEPTIVE BIOSYSTEMS, INC. (US) | 2002-11-14 | — | — | WO | disclosed |
| US-20020159994-A1 | Biotin derivatives | GLYCOREX TRANSPLANTATION AB (SE) | 2002-10-31 | — | — | US | disclosed |
| US-6472153-B1 | COVALENTLY BOUND OLIGONUCLEOTIDE/MINOR GROOVE BINDER/LATENT FLUOROPHORE COMBINATION | EPOCH BIOSCIENCES, INC. | 2002-10-29 | — | — | US | disclosed |
| EP-1144429-A3 | HYBRIDIZATION AND MISMATCH DISCRIMINATION USING OLIGONUCLEOTIDES CONJUGATED TO MINOR GROOVE BINDERS | Epoch Pharmaceuticals, Inc. (US) | 2002-09-11 | — | — | EP | disclosed |
| WO-2002059144-A2 | DIFFERENTIAL LABELING FOR QUANTITATIVE ANALYSIS OF COMPLEX PROTEIN MIXTURES | SYNGENTA PARTICIPATION AG (US) | 2002-08-01 | — | — | WO | disclosed |
| US-6426408-B1 | PLURALITY OF NUCLEOTIDE UNITS WITH LINKING GROUP | EPOCH BIOSCIENCES, INC. | 2002-07-30 | — | — | US | disclosed |
| EP-1224332-A1 | HYBRIDIZATION-TRIGGERED FLUORESCENT DETECTION OF NUCLEIC ACIDS | Epoch Biosciences, Inc. (US) | 2002-07-24 | — | — | EP | disclosed |
| US-20020090652-A1 | Inverse labeling method for the rapid identification of marker/target proteins | FU EMIL WEI-MING (US) | 2002-07-11 | — | — | US | disclosed |
| WO-2002052271-A2 | INVERSE LABELING METHOD FOR THE RAPID IDENTIFICATION OF MARKER/TARGET PROTEINS | NOVARTIS AG (CH) | 2002-07-04 | — | — | WO | disclosed |
| US-20020076739-A1 | Rapid quantitative analysis of proteins or protein function in complex mixtures | UNIVERSITY OF WASHINGTON | 2002-06-20 | — | — | US | disclosed |
| US-20020052482-A1 | Covalently linked oligonucleotide minor grove binder conjugates | MICROPROBE | 2002-05-02 | — | — | US | disclosed |
| US-20020049307-A1 | Selective labeling and isolation of phosphopeptides and applications to proteome analysis | WASHINGTON, UNIVERSITY OF | 2002-04-25 | — | — | US | disclosed |
| WO-2001095857-A2 | REUSABLE EXTRACORPOREAL COLUMS LOADED WITH LIGAND-DIBIOTIN CONJUGATES | MITRA MEDICAL TECHNOLOGY AB (SE) | 2001-12-20 | — | — | WO | disclosed |
| WO-2001096869-A1 | SELECTIVE LABELING AND ISOLATION OF PHOSPHOPEPTIDES AND APPLICATIONS TO PROTEOME ANALYSIS | UNIVERSITY OF WASHINGTON (US) | 2001-12-20 | — | — | WO | disclosed |
| US-6312953-B1 | MODIFIED OLIGONUCLEOTIDE COMPLEMENTARY TO A TARGET SEQUENCE AND HAVING AT LEAST TWO CROSSLINKING AGENTS COVALENTLY ATTATCHED; GENE EXPRESSION INHIBITION; DNA SEQUENCING; GENETIC MAPPING | EPOCH PHARMACEUTICALS, INC. | 2001-11-06 | — | — | US | disclosed |
| US-6312894-B1 | HYBRIDIZATION OF OLIGONUCLEOTIDES AND MINOR GROOVE BINDER COMBINATION; WHERE THE MINOR GROOVE BINDER BINDS IN A NON-INTERCALATING MANNER WITH A HIGHER ASSOCIATION CONSTANT | EPOCH PHARMACEUTICALS, INC. | 2001-11-06 | — | — | US | disclosed |
| EP-1144429-A2 | HYBRIDIZATION AND MISMATCH DISCRIMINATION USING OLIGONUCLEOTIDES CONJUGATED TO MINOR GROOVE BINDERS | Epoch Pharmaceuticals, Inc. (US) | 2001-10-17 | — | — | EP | disclosed |
| WO-2001031063-A1 | HYBRIDIZATION-TRIGGERED FLUORESCENT DETECTION OF NUCLEIC ACIDS | EPOCH BIOSCIENCES, INC. (US) | 2001-05-03 | — | — | WO | disclosed |
| US-6143877-A | FORMING A TRIPLEX BY CONTACTING DUPLEX NUCLEIC ACID HAVING A TARGET SEQUENCE OF PURINE BASES WITH A OLIGONUCLEOTIDE HAVING AT LEAST ONE GUANINE BASE REPLACED BY 6-AMINO-1H-PYRAZOLO(3,4-D)PYRIMIDIN-4(5H)-ONE | EPOCH PHARMACEUTICALS, INC. (US) | 2000-11-07 | — | — | US | disclosed |
| US-6084102-A | THE OLIGONUCLEOTIDE IS COMPLEMENTARY TO A TARGET SEQUENCE OF SINGLE STRANDED OR DOUBLE STRANDED DNA, RNA OR HYBRIDS AND, WHEN USED AS A PROBE, BINDS MORE STRONGLY BECAUSE OF THE BOUND MINOR GROVE BINDER; MEDICAL DIAGNOSIS; ANTISENSE THERAPY | EPOCH PHARMACEUTICALS, INC. (US) | 2000-07-04 | — | — | US | disclosed |
| US-6072046-A | SELECTIVELY FORM TRIPLEXES WITH A COMPLEMENTARY TARGET SEQUENCE IN DOUBLE-STRANDED DNA AND EFFICIENTLY CROSSLINK WITH BOTH STRANDS; THERAPEUTICS, DIAGNOSTICS, AND GENETIC PROBES | EPOCH PHARMACEUTICALS, INC. (US) | 2000-06-06 | — | — | US | disclosed |
| WO-2000012523-A1 | DIAZIRIDINYL-ARYL AND BIS-[DI(CHLOROETHYL)AMINO]-ARYL OLIGONUCLEOTIDE CONJUGATES AND REAGENTS FOR MAKING THE SAME | EPOCH PHARMACEUTICALS, INC. (US) | 2000-03-09 | — | — | WO | disclosed |
| WO-1999051621-A2 | HYBRIDIZATION AND MISMATCH DISCRIMINATION USING OLIGONUCLEOTIDES CONJUGATED TO MINOR GROOVE BINDERS | EPOCH PHARMACEUTICALS, INC. (US) | 1999-10-14 | — | — | WO | disclosed |
| US-5912340-A | FORMING STABLE HYBRID WITH DNA, RNA | EPOCH PHARMACEUTICALS, INC. (US) | 1999-06-15 | — | — | US | disclosed |
| US-5849482-A | Crosslinking oligonucleotides | EPOCH PHARMACEUTICALS, INC. (US) | 1998-12-15 | — | — | US | disclosed |
| WO-1998049180-A1 | TRIPLEX FORMING OLIGONUCLEOTIDES INCLUDING PYRAZOLO(3,4-D)PYRIMIDINE BASES | EPOCH PHARMACEUTICALS, INC. (US) | 1998-11-05 | — | — | WO | disclosed |
| US-5801155-A | Covalently linked oligonucleotide minor grove binder conjugates | EPOCH PHARMACEUTICALS, INC. (US) | 1998-09-01 | — | — | US | disclosed |
| CN-1186496-A | Covalently bound oligonucleotide minor groove binder conjugates | IBORCH PHARMACEUTICAL CORP (US) | 1998-07-01 | — | — | CN | disclosed |
| EP-0842186-A1 | CROSS-LINKING OLIGONUCLEOTIDES | MICROPROBE CORPORATION (US) | 1998-05-20 | — | — | EP | disclosed |
| EP-0819133-A2 | COVALENTLY LINKED OLIGONUCLEOTIDE MINOR GROOVE BINDER CONJUGATES | EPOCH PHARMACEUTICALS, INC. (US) | 1998-01-21 | — | — | EP | disclosed |
| US-5665562-A | SCINTILLATION PROXIMITY ASSAY USING RADIOISOTOPE-LABELLED REAGENT | AMERSHAM INTERNATIONAL PLC (GB) | 1997-09-09 | — | — | US | disclosed |
| WO-1997029114-A1 | BIOTIN-CONTAINING COMPOUNDS, BIOTINYLATION REAGENTS AND METHODS | BOARD OF REGENTS OF THE UNIVERSITY OF WASHINGTON (US) | 1997-08-14 | — | — | WO | disclosed |
| US-5646126-A | ANTITUMOR AGENTS EFFECTIVE AGAINST MULTIPLE DRUG RESISTANT CELL LINES | EPOCH PHARMACEUTICALS | 1997-07-08 | — | — | US | disclosed |
| WO-1997012896-A1 | SELECTIVE BINDING COMPLEMENTARY OLIGONUCLEOTIDES | EPOCH PHARMACEUTICALS, INC. (US) | 1997-04-10 | — | — | WO | disclosed |
| EP-0748331-A1 | MODIFIED OLIGONUCLEOTIDE DUPLEXES HAVING ANTICANCER ACTIVITY | EPOCH PHARMACEUTICALS, INC. (US) | 1996-12-18 | — | — | EP | disclosed |
| WO-1996032496-A2 | COVALENTLY LINKED OLIGONUCLEOTIDE MINOR GROOVE BINDER CONJUGATES | MICROPROBE CORPORATION (US) | 1996-10-17 | — | — | WO | disclosed |
| WO-1995023162-A1 | MODIFIED OLIGONUCLEOTIDE DUPLEXES HAVING ANTICANCER ACTIVITY | MICROPROBE CORPORATION (US) | 1995-08-31 | — | — | WO | disclosed |
| US-5419966-A | Solid support for synthesis of 3'-tailed oligonucleotides | MICROPROBE CORPORATION (US) | 1995-05-30 | — | — | US | disclosed |
| EP-0547142-A4 | — | MICROPROBE CORP (US) | 1995-01-18 | — | — | EP | disclosed |
| WO-1994017092-A1 | BIFUNCTIONAL CROSSLINKING OLIGONUCLEOTIDES ADAPTED FOR LINKING TO A DESIRED GENE SEQUENCE OF INVADING ORGANISM OR CELL | MICROPROBE CORPORATION (US) | 1994-08-04 | — | — | WO | disclosed |
| EP-0547142-A1 | SOLID SUPPORT SYNTHESIS OF 3'-TAILED OLIGONUCLEOTIDES VIA A LINKING MOLECULE | EPOCH PHARMACEUTICALS, INC. (US) | 1993-06-23 | — | — | EP | disclosed |
| WO-1992003464-A1 | SOLID SUPPORT SYNTHESIS OF 3'-TAILED OLIGONUCLEOTIDES VIA A LINKING MOLECULE | MICROPROBE CORPORATION (US) | 1992-03-05 | — | — | WO | disclosed |
| WO-1992003464-A1 | SOLID SUPPORT SYNTHESIS OF 3'-TAILED OLIGONUCLEOTIDES VIA A LINKING MOLECULE | MICROPROBE CORPORATION (US) | 1992-03-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140155585-A1 | HAPTENS OF RISPERIDONE AND PALIPERIDONE | PRLHR, HRH1, OPRL1 | CA1 4448/4885CA2 4630/4885CA4 4081/4885 |
| US-20020052482-A1 | Covalently linked oligonucleotide minor grove binder conjugates | CD2BP2, MICA, SELPLG | CA1 4363/4885CA2 4524/4885CA4 3522/4885 |
| US-10793644-B2 | Antibodies to risperidone haptens and use thereof | HTR4, HTR3C, OPRL1 | CA1 3959/4885CA2 4273/4885CA4 3544/4885 |
| US-20240010657-A1 | BIOTIN DERIVATIVES | BTD, HLCS, BRI3BP | CA1 4859/4885CA2 4696/4885CA4 4354/4885 |
| US-20140163206-A1 | HAPTENS OF ARIPIPRAZOLE | HRH2, HRH4, CYP2D6 | CA1 1726/4885CA2 1955/4885CA4 1237/4885 |
| US-20180105606-A1 | ANTIBODIES TO QUETIAPINE HAPTENS AND USE THEREOF | HTR4, HTR3C, SLC6A4 | CA1 3821/4885CA2 3800/4885CA4 2714/4885 |
| US-20020076739-A1 | Rapid quantitative analysis of proteins or protein function in complex mixtures | PRTN3, RPS27A, PA2G4 | CA1 2941/4885CA2 3539/4885CA4 3418/4885 |
| US-20140017797-A1 | PROTEIN AFFINITY TAG AND USES THEREOF | PTMS, ALPG, TPX2 | CA1 1648/4885CA2 1002/4885CA4 1108/4885 |
| US-20050064463-A1 | Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders | DDB1, LIG3, MSH2 | CA1 2672/4885CA2 3638/4885CA4 3648/4885 |
| US-11225527-B2 | Antibodies to paliperidone haptens and use thereof | LY96, OPRL1, HTR3C | CA1 4339/4885CA2 4111/4885CA4 3081/4885 |
| US-20170044372-A1 | CELL TRACKING REAGENTS AND THEIR METHODS OF USE | MKI67, DCX, NES | CA1 3205/4885CA2 3734/4885CA4 3300/4885 |
| US-10166296-B2 | Haptens of aripiprazole | HRH2, HRH4, CYP2D6 | CA1 1726/4885CA2 1955/4885CA4 1237/4885 |
| US-11731982-B2 | Biotin derivatives | BTD, HLCS, BRI3BP | CA1 4859/4885CA2 4696/4885CA4 4354/4885 |
| US-10370457-B2 | Antibodies to paliperidone haptens and use thereof | LY96, OPRL1, HTR3C | CA1 4339/4885CA2 4111/4885CA4 3081/4885 |
| US-11226345-B2 | Antibodies to olanzapine haptens and use thereof | HTR4, HTR3C, HTR1A | CA1 3724/4885CA2 4350/4885CA4 3519/4885 |
| US-20140057305-A1 | Antibodies to Quetiapine Haptens and Use Thereof | HTR4, HTR3C, SLC6A4 | CA1 3821/4885CA2 3800/4885CA4 2714/4885 |
| US-20180117169-A1 | HAPTENS OF ARIPIPRAZOLE | HRH2, HRH4, CYP2D6 | CA1 1726/4885CA2 1955/4885CA4 1237/4885 |
| US-20170298147-A1 | ANTIBODIES TO PALIPERIDONE HAPTENS AND USE THEREOF | LY96, OPRL1, HTR3C | CA1 4339/4885CA2 4111/4885CA4 3081/4885 |
| US-20140011255-A1 | Biotin Derivatives | BTD, HLCS, BRI3BP | CA1 4859/4885CA2 4696/4885CA4 4354/4885 |
| US-10465013-B2 | Antibodies to quetiapine haptens and use thereof | HTR4, HTR3C, SLC6A4 | CA1 3821/4885CA2 3800/4885CA4 2714/4885 |
| US-20140057301-A1 | Antibodies to Risperidone Haptens and Use Thereof | HTR4, HTR3C, OPRL1 | CA1 3959/4885CA2 4273/4885CA4 3544/4885 |
| US-10712353-B2 | Antibodies to olanzapine haptens and use thereof | HTR4, HTR3C, HTR1A | CA1 3724/4885CA2 4350/4885CA4 3519/4885 |
| US-20190322681-A1 | Biotin Derivatives | BTD, HLCS, BRI3BP | CA1 4859/4885CA2 4696/4885CA4 4354/4885 |
| US-20200399400-A1 | ANTIBODIES TO RISPERIDONE HAPTENS AND USE THEREOF | HTR4, HTR3C, OPRL1 | CA1 3959/4885CA2 4273/4885CA4 3544/4885 |
| US-20070166723-A1 | Hybridization-triggered fluorescent detection of nucleic acids | DDX21, RNGTT, NOP2 | CA1 739/4885CA2 692/4885CA4 494/4885 |
| US-20140213766-A1 | HAPTENS OF OLANZIPINE | OPRL1, ADRA1D, CHRNA2 | CA1 2147/4885CA2 1803/4885CA4 2885/4885 |
| US-10570250-B2 | Dibenzosilole monomers and polymers and methods for their preparation and use | DDOST, DDT, DAD1 | CA1 1725/4885CA2 4283/4885CA4 3328/4885 |
| US-20030113765-A1 | Hybridization-triggered fluorescent detection of nucleic acids | DDX21, RNGTT, NOP2 | CA1 739/4885CA2 692/4885CA4 494/4885 |
| US-20180355098-A1 | DIBENZOSILOLE MONOMERS AND POLYMERS AND METHODS FOR THEIR PREPARATION AND USE | DDOST, DDT, DAD1 | CA1 1725/4885CA2 4283/4885CA4 3328/4885 |
| US-20200040107-A1 | ANTIBODIES TO QUETIAPINE HAPTENS AND USE THEREOF | HTR4, HTR3C, SLC6A4 | CA1 3821/4885CA2 3800/4885CA4 2714/4885 |
| US-20090048427-A1 | HYBRIDIZATION AND MISMATCH DISCRIMINATION USING OLIGONUCLEOTIDES CONJUGATED TO MINOR GROOVE BINDERS | DDB1, LIG3, MSH2 | CA1 2672/4885CA2 3638/4885CA4 3648/4885 |
| US-20190338047-A1 | Antibodies to Paliperidone Haptens and Use Thereof | LY96, OPRL1, HTR3C | CA1 4339/4885CA2 4111/4885CA4 3081/4885 |
| US-20170247504-A1 | DIBENZOSILOLE MONOMERS AND POLYMERS AND METHODS FOR THEIR PREPARATION AND USE | DDOST, DDT, DAD1 | CA1 1725/4885CA2 4283/4885CA4 3328/4885 |
| US-20140213767-A1 | HAPTENS OF PALIPERIDONE | CD274, PIN1, LY96 | CA1 4497/4885CA2 4446/4885CA4 2983/4885 |
| US-20170204198-A1 | Antibodies to Aripiprazole Haptens and Use Thereof | FCER2, HTR4, HTR3C | CA1 3272/4885CA2 3267/4885CA4 2388/4885 |
| US-20180022827-A1 | ANTIBODIES TO RISPERIDONE HAPTENS AND USE THEREOF | HTR4, HTR3C, OPRL1 | CA1 3959/4885CA2 4273/4885CA4 3544/4885 |
| US-20030087329-A1 | Differential labeling for quantitative analysis of complex protein mixtures | RPS27A, PSMG3, MRTO4 | CA1 1492/4885CA2 2431/4885CA4 2019/4885 |
| US-10379105-B2 | Antibodies to aripiprazole haptens and use thereof | FCER2, HTR4, HTR3C | CA1 3272/4885CA2 3267/4885CA4 2388/4885 |
| US-20140057303-A1 | Antibodies to Olanzapine Haptens and Use Thereof | HTR4, HTR3C, HTR1A | CA1 3724/4885CA2 4350/4885CA4 3519/4885 |
| US-20120045848-A1 | PYRENYLOXYSULFONIC ACID FLUORESCENT AGENTS | NOP56, ANXA5, ANXA6 | CA1 818/4885CA2 1054/4885CA4 619/4885 |
| US-20070031973-A1 | Triazine derivatives as universal peptide isotope tag reagents (U-PIT) | QPCTL, PTMS, RPS27A | CA1 1564/4885CA2 3272/4885CA4 2174/4885 |
| US-20040052784-A1 | Biotin derivatives | BTD, HLCS, PROC | CA1 2875/4885CA2 4580/4885CA4 4051/4885 |
| US-20190331663-A1 | Antibodies to Aripiprazole Haptens and Use Thereof | FCER2, HTR4, HTR3C | CA1 3272/4885CA2 3267/4885CA4 2388/4885 |
| US-20060228325-A1 | Water soluble multi-biotin-containing compounds | BTD, HLCS, VNN1 | CA1 3043/4885CA2 3940/4885CA4 4092/4885 |
| US-20170240653-A1 | ANTIBODIES TO OLANZAPINE HAPTENS AND USE THEREOF | HTR4, HTR3C, HTR1A | CA1 3724/4885CA2 4350/4885CA4 3519/4885 |
| US-20050136008-A1 | Polybiotin compounds for magnetic resonance imaging and drug delivery | BTD, BCAT1, BRD4 | CA1 3221/4885CA2 2358/4885CA4 1241/4885 |
| US-20040259164-A1 | Capture and release based isotope tagged peptides and methods for using the same | PTMS, RPS27A, RBBP5 | CA1 3854/4885CA2 4459/4885CA4 4185/4885 |
| US-20180149637-A1 | ANTIBODIES TO ARIPIPRAZOLE HAPTENS AND USE THEREOF | FCER2, HTR4, HTR3C | CA1 3272/4885CA2 3267/4885CA4 2388/4885 |
| US-20090010845-A1 | Polybiotin Compounds of Magnetic Resonance Imaging and Drug Delivery | BTD, BCAT1, BRD4 | CA1 3194/4885CA2 2342/4885CA4 1285/4885 |
| US-20140057299-A1 | Antibodies to Aripiprazole Haptens and Use Thereof | FCER2, HTR4, HTR3C | CA1 3272/4885CA2 3267/4885CA4 2388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.